Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.67 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.67 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.67 |
| ▸ | PAM | P19021 | 1/20 | 0.51 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.51 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 3/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.45 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.45 |
| ▸ | PPARG | P37231 | 1/20 | 0.43 |
| ▸ | PPARA | Q07869 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19917497 | 0.83 | ALDH1A1 (0.53) | ALDH1A1MAPK1L3MBTL1ALOX5NPC1 | |
| SCHEMBL27499661 | 0.81 | ALDH1A1 (0.92) | ALDH1A1MAPK1L3MBTL1PAMENPP2 | |
| SCHEMBL361779 | 0.81 | ALDH1A1 (1.00) | ALDH1A1MAPK1L3MBTL1PAMENPP2 | |
| SCHEMBL12368043 | 0.80 | CYP4Z1 (0.46) | ALDH1A1ALOX5SMN1; SMN2 | |
| SCHEMBL11791534 | 0.80 | ALDH1A1 (0.47) | ALDH1A1MAPK1L3MBTL1NPC1RAB9A | |
| SCHEMBL6784181 | 0.79 | ALDH1A1 (0.96) | ALDH1A1MAPK1L3MBTL1PAMENPP2 | |
| SCHEMBL3042119 | 0.79 | TDP1 (0.64) | ALDH1A1L3MBTL1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL21012091 | 0.79 | ALDH1A1 (0.69) | ALDH1A1MAPK1L3MBTL1PAMNPC1 | |
| SCHEMBL5793165 | 0.79 | ALDH1A1 (0.55) | ALDH1A1MAPK1L3MBTL1PAMSMN1; SMN2 | |
| SCHEMBL29169367 | 0.79 | L3MBTL1 (0.79) | ALDH1A1MAPK1L3MBTL1PAMNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060079696-A1 | Substituted compounds derived from N-(benzyl)phenylacetamide, preparation and uses | GENFIT (FR) | 2006-04-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060079696-A1 | Substituted compounds derived from N-(benzyl)phenylacetamide, preparation and uses | AADAC, NAT1, PARN | ALDH1A1 845/4885MAPK1 3624/4885L3MBTL1 2320/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.